Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04095273 |
|---|---|
| Brief Title: | Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug |
| First Submitted : | September 18, 2019 |
| First Submitted that Met QC Criteria : | September 18, 2019 |
| First Posted : | September 19, 2019 |
| Last Update Submitted that Met QC Criteria : | February 15, 2023 |
| Last Update Posted : | February 16, 2023 |